Cargando…

Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India

Lymphatic filariasis (LF) is a vector-borne neglected tropical disease, causing permanent disability. The disease is debilitating and widespread, leading to tremendous productivity and economic loss. The Government of India (GOI) prioritized the elimination of LF through the annual mass drug adminis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sabesan, S., Krishnamoorthy, K., Hoti, S.L., Subramanian, S., Srividya, A., Roy, Nupur, Jain, Tanu, Kumar, Ashwani, Rahi, Manju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Policy Guidelines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707683/ https://www.ncbi.nlm.nih.gov/pubmed/36124509 http://dx.doi.org/10.4103/ijmr.ijmr_171_22

Ejemplares similares

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India
por: Jambulingam, Purushothaman, et al.
Publicado: (2021)

Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
por: Khaemba, Christabel, et al.
Publicado: (2021)

Global Programme to Eliminate Lymphatic Filariasis: The Processes Underlying Programme Success
por: Ichimori, Kazuyo, et al.
Publicado: (2014)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa
por: Fischer, Peter U., et al.
Publicado: (2017)

The Global Programme to Eliminate Lymphatic Filariasis: History and achievements with special reference to annual single-dose treatment with diethylcarbamazine in Samoa and Fiji
por: Kimura, Eisaku
Publicado: (2011)

Lessons Learned from the Japanese Encephalitis Vaccine Introduction in India That Supported the Introduction of Ivermectin–Diethylcarbamazine–Albendazole for Lymphatic Filariasis Elimination
por: Ghosh, Raj Shankar, et al.
Publicado: (2022)

Mapping and monitoring for a lymphatic filariasis elimination program: a systematic review
por: Srividya, Adinarayanan, et al.
Publicado: (2019)

India can consider integration of three eliminable disease control programmes on malaria, lymphatic filariasis, and visceral leishmaniasis
por: Rahi, Manju, et al.
Publicado: (2021)

Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis
por: Jambulingam, Purushothaman, et al.
Publicado: (2022)

Correction: India can consider integration of three eliminable disease control programmes on malaria, lymphatic filariasis, and visceral leishmaniasis
por: Rahi, Manju, et al.
Publicado: (2022)

Elimination of Lymphatic Filariasis in The Gambia
por: Rebollo, Maria P., et al.
Publicado: (2015)

India could harness public-private partnerships to achieve malaria elimination
por: Rahi, Manju, et al.
Publicado: (2022)

Malaria control initiatives that have the potential to be gamechangers in India's quest for malaria elimination
por: Rahi, Manju, et al.
Publicado: (2022)

Delimitation of lymphatic filariasis transmission risk areas: a geo-environmental approach
por: Sabesan, Shanmugavelu, et al.
Publicado: (2006)

The history of the elimination of lymphatic filariasis in China
por: De-jian, Sun, et al.
Publicado: (2013)

Evaluating the Evidence for Lymphatic Filariasis Elimination
por: Davis, Emma L., et al.
Publicado: (2019)

Pacific collaboration to eliminate lymphatic filariasis
por: Ichimori, Kazuyo, et al.
Publicado: (2005)

Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India
por: Subramanian, Swaminathan, et al.
Publicado: (2020)

Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial
por: Laman, Moses, et al.
Publicado: (2022)

Epidemiological Assessment of Eight Rounds of Mass Drug Administration for Lymphatic Filariasis in India: Implications for Monitoring and Evaluation
por: Swaminathan, Subramanian, et al.
Publicado: (2012)

Filariasis Control with Diethylcarbamazine in Three Major Endemic Areas in Japan
por: Tada, Isao
Publicado: (2011)

Introduction of Triple-Drug Therapy for Accelerating Lymphatic Filariasis Elimination in India: Lessons Learned
por: Tripathi, Bhupendra, et al.
Publicado: (2022)

Application of a household-based molecular xenomonitoring strategy to evaluate the lymphatic filariasis elimination program in Tamil Nadu, India
por: Subramanian, Swaminathan, et al.
Publicado: (2017)

Progress on elimination of lymphatic filariasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2018)

Elimination of lymphatic filariasis in South East Asia
por: Specht, Sabine, et al.
Publicado: (2019)

Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis
por: Chhonker, Yashpal S., et al.
Publicado: (2023)

Filariasis of uncommon nature in India
por: Hoti, SL
Publicado: (2012)

A Success Story: Togo Is Moving toward Becoming the First Sub-Saharan African Nation to Eliminate Lymphatic Filariasis through Mass Drug Administration and Countrywide Morbidity Alleviation
por: Sodahlon, Yao K., et al.
Publicado: (2013)

Developing Eradication Investment Cases for Onchocerciasis, Lymphatic Filariasis, and Human African Trypanosomiasis: Rationale and Main Challenges
por: Tediosi, Fabrizio, et al.
Publicado: (2013)

Mathematical models for lymphatic filariasis transmission and control: Challenges and prospects
por: Swaminathan, Subramanian, et al.
Publicado: (2008)

Defining the cost of the Egyptian lymphatic filariasis elimination programme
por: Ramzy, Reda MR, et al.
Publicado: (2005)

Lymphatic filariasis in Brazil: epidemiological situation and outlook for elimination
por: Fontes, Gilberto, et al.
Publicado: (2012)

Population Migration: Implications for Lymphatic Filariasis Elimination Programmes
por: Ramaiah, K. D.
Publicado: (2013)

Achievements and challenges of lymphatic filariasis elimination in Sierra Leone
por: Bah, Yakuba M., et al.
Publicado: (2020)

Progress towards elimination of lymphatic filariasis in the Americas region
por: Fontes, Gilberto, et al.
Publicado: (2020)

Caring for patients in the global programme to eliminate lymphatic filariasis
por: Mackenzie, Charles D, et al.
Publicado: (2020)

A Low-Tech Analytical Method for Diethylcarbamazine Citrate in Medicated Salt
por: Weaver, Abigail, et al.
Publicado: (2011)

Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
por: Allen, Tammy, et al.
Publicado: (2017)

Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study
por: Pani, SP, et al.
Publicado: (2002)

Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China
por: Fang, Yuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dq4ki3u8gh7seg9p13498a9lkv